Odonate Therapeutics, Inc. (ODTC)

OTCMKTS: ODTC · Delayed Price · USD

3,500.00

+75.00 (2.19%)

Apr 8, 2024, 3:27 PM EDT - Market closed

Odonate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2020	2019	2018	2017	2016	2015
Selling, General & Admin	10.39	10.9	10.82	4.84	0.46	0.16
Research & Development	117.04	104.03	79.95	27.9	2.62	0
Other Operating Expenses	1.08	0	0	0	0	0
Operating Expenses	127.43	114.93	90.76	32.74	3.09	0.16
Operating Income	-127.43	-114.93	-90.76	-32.74	-3.09	-0.16
Interest Income	0	3.11	1.8	0	0	0
Other Expense / Income	-1.08	-	-1.8	-	-	-
Pretax Income	-126.35	-111.83	-88.96	-32.74	-3.09	-0.16
Income Tax	0	-3.11	1.8	0	0	0
Net Income	-126.35	-108.72	-88.96	-32.74	-3.09	-0.16
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change	18.96%	12.12%	73.87%	-49.08%	-	-
EPS (Basic)	-7689.73	-7871.42	-7221.37	-4621.59	-221.74	-11.36
EPS (Diluted)	-7689.73	-7871.42	-7221.37	-4621.59	-221.74	-11.36
Free Cash Flow	-113.56	-96.8	-69	-25.94	-1.73	-0.17
Free Cash Flow Per Share	-6911.45	-7008.69	-5601.19	-3661.40	-124.56	-11.86
EBITDA	-126.99	-114.55	-90.41	-32.72	-3.09	-0.16
Depreciation & Amortization	0.45	0.38	0.35	0.02	0	0
EBIT	-127.43	-114.93	-90.76	-32.74	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.